CVS Health’s Q3 medical benefit ratio landed at 91.3%, squarely inside the 90.5–92% band that commanded near-certain market-implied odds. The primary driver was a 150-basis-point year-over-year improvement in the Health Care Benefits segment, driven by better underlying performance in the Government business, disciplined Medicare Advantage pricing, and favorable prior-period reserve development. Analyst consensus and company guidance entering the quarter had centered on low-to-mid-90s MBR levels, consistent with the company’s multi-year margin-recovery plan and historical base rates for large managed-care firms. A surprise spike in utilization or adverse reserve development remains the main scenario that could have pushed the ratio above 92%.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano1H6H1D7D30DALL
View resolved

Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania